Search research articles
Contact Us
Filters
Showing results (31-40 of 37) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 37 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 1, 1994
Long-term prognostic importance of primary Ki-1 (CD30) antigen expression and anaplastic morphology in adult patients with diffuse large-cell lymphoma
J E Romaguera, J T Manning, C S Tornos, et al.
Blood
|
September 1, 1996
Amplification of genomic DNA demonstrates the presence of the t(2;5) (p23;q35) in anaplastic large cell lymphoma, but not in other non-Hodgkin's lymphomas, Hodgkin's disease, or lymphomatoid papulosis
A H Sarris, R Luthra, V Papadimitracopoulou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 1, 1997
Long-range amplification of genomic DNA detects the t(2;5)(p23;q35) in anaplastic large-cell lymphoma, but not in other non-Hodgkin's lymphomas, Hodgkin's disease, or lymphomatoid papulosis
A H Sarris, R Luthra, V Papadimitracopoulou, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 29, 1999
Apoptosis and the Bcl-2 gene family -- patterns of expression and prognostic value in stage I and II follicular center lymphoma
M D Logsdon, R E Meyn, P C Besa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 16, 1998
Hyper-CVAD and high-dose methotrexate/cytarabine followed by stem-cell transplantation: an active regimen for aggressive mantle-cell lymphoma
I F Khouri, J Romaguera, H Kantarjian, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 1, 1997
Allogeneic transplantation for recurrent or refractory non-Hodgkin's lymphoma with poor prognostic features after conditioning with thiotepa, busulfan, and cyclophosphamide: experience in 44 consecutive patients
K van Besien, P Thall, M Korbling, et al.
The American Journal of Medicine
|
March 1, 1996
Allogeneic bone marrow transplantation for poor-prognosis lymphoma: response, toxicity and survival depend on disease histology
K W van Besien, R C Mehra, S A Giralt, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 37) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 37 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 1, 1994
Long-term prognostic importance of primary Ki-1 (CD30) antigen expression and anaplastic morphology in adult patients with diffuse large-cell lymphoma
J E Romaguera, J T Manning, C S Tornos, et al.
Blood
|
September 1, 1996
Amplification of genomic DNA demonstrates the presence of the t(2;5) (p23;q35) in anaplastic large cell lymphoma, but not in other non-Hodgkin's lymphomas, Hodgkin's disease, or lymphomatoid papulosis
A H Sarris, R Luthra, V Papadimitracopoulou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 1, 1997
Long-range amplification of genomic DNA detects the t(2;5)(p23;q35) in anaplastic large-cell lymphoma, but not in other non-Hodgkin's lymphomas, Hodgkin's disease, or lymphomatoid papulosis
A H Sarris, R Luthra, V Papadimitracopoulou, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 29, 1999
Apoptosis and the Bcl-2 gene family -- patterns of expression and prognostic value in stage I and II follicular center lymphoma
M D Logsdon, R E Meyn, P C Besa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 16, 1998
Hyper-CVAD and high-dose methotrexate/cytarabine followed by stem-cell transplantation: an active regimen for aggressive mantle-cell lymphoma
I F Khouri, J Romaguera, H Kantarjian, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 1, 1997
Allogeneic transplantation for recurrent or refractory non-Hodgkin's lymphoma with poor prognostic features after conditioning with thiotepa, busulfan, and cyclophosphamide: experience in 44 consecutive patients
K van Besien, P Thall, M Korbling, et al.
The American Journal of Medicine
|
March 1, 1996
Allogeneic bone marrow transplantation for poor-prognosis lymphoma: response, toxicity and survival depend on disease histology
K W van Besien, R C Mehra, S A Giralt, et al.
Page
of 4